Expert Insights Webinars

Award-winning experts share their detailed and actionable insights to inform 

the future of pharma and biotech.

LATEST WEBINAR

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development - Expert Webinar

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, and eCTD Submission

This webinar highlights the roadmap to efficiently navigate important aspects of Type II DMF management, quality components, and submission strategies that are essential for seamless filing and maintenance.

ON-DEMAND WEBINARS

 WISDOM Study: Revolutionizing Breast Cancer Screening

The Wisdom Study: Revolutionizing Breast Cancer Screening, Detection & Prevention

EU CTR Compliance and Success: Navigating Updates and Preparing Submissions for the EU CTIS Portal

EU CTR Compliance and Success: Navigating Updates and Preparing Submissions for the EU CTIS Portal

How to Submit Non-Clinical Data to CBER Using SEND : Understanding New FDA Requirements

How to Submit Non-Clinical Data to CBER Using SEND : Understanding New FDA Requirements

Data Management Considerations for Decentralized Clinical Trial Implementation

Data Management Considerations for Decentralized Clinical Trial Implementation

How to Create Fit For-Purpose Clinical Study Reports for Successful Submissions

How to Create Fit-For-Purpose Clinical Study Reports for Successful Submissions

Using Natural Language Processing (NLP) to curate unstructured EHR

Using Natural Language Processing (NLP) to curate unstructured EHR

Strategies for Navigating ICH E9(R1)

Strategies for Navigating ICH E9(R1)

Insights and Trends from 2021 FDA GCP Inspections.

Insights and Trends from 2021 FDA GCP Inspections.

Tips for Effective and Efficient New Drug Application (NDA) Submissions

Tips for Effective and Efficient New Drug Application (NDA) Submissions

Strategies for Rare Disease Data Analysis: Doing More with Less

Strategies for Rare Disease Data Analysis: Doing More with Less

Orphan Drug, Rare Pediatric Disease and Expedited Program Designations

Orphan Drug, Rare Pediatric Disease and Expedited Program Designations

Rare Disease Research in the United States, Part 2

Rare Disease Research in the United States, Part 2

Rare Disease Research in the United States, Part 1

Rare Disease Research in the United States, Part 1

The Blueprint for Success for Effective and Efficient Clinical Protocols

The Blueprint for Success for Effective and Efficient Clinical Protocols

EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

Avoiding Common Pitfalls in the IND and CTA Submission Process

Avoiding Common Pitfalls in the IND and CTA Submission Process

Evolving Your FSP Relationships to Achieve Maximum Return

Evolving Your FSP Relationships to Achieve Maximum Return

How to Use Machine Learning in Clinical Research Right Now

How to Use Machine Learning in Clinical Research Right Now

Best Practices for Data Visualization in Pharma, presented by MMS Holdings Data Science leaders

Best Practices for Data Visualization in Pharma, presented by MMS Holdings Data Science leaders